HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Blood In The Water? L’Oreal Hit With New Keratin Fraud Complaint As Matrix Suit Advances

Executive Summary

L’Oreal USA is in Phase II expert discovery in a certified class action alleging that the absence of keratin in its Matrix Biolage Keratindose hair-care line misleads consumers. Now the firm faces similar allegations, also in New York’s Southern District, about a L’Oreal Paris Keratin Caring range.   

You may also be interested in...

L’Oreal’s Gunslinging Counsel On Killing Amla Hair-Relaxer Class Action: ‘We Shot Every Bullet’

Gordon & Rees partner Peter Siachos for L’Oreal says the firm was “relentless” in its defense against a consolidated class action in New York’s Southern District concerning the SoftSheen Carson Amla Legend hair relaxer. Plaintiffs alleged the product is unreasonably dangerous and, at the same time, deceptively marketed as a gentler option than competing, lye-based offerings.

Where’s The Keratin? L’Oreal/Matrix Hair Line Falsely Advertised – Lawsuit

Following a complaint filed in late January, L’Oreal will be defending labeling and advertising for Matrix Biolage Keratindose hair-care line in New York’s Southern District, the same court where claims and safety for a Soft Sheen-Carson hair relaxer are being challenged in a separate class action. Plaintiffs in the Keratindose suit allege the line is deceptively marketed because formulas contain no actual keratin.

Estee Lauder Companies Sees Regional Signs Of ‘Makeup Renaissance’

During ELC’s third-quarter earnings call, leadership cited China, Australia and Israel as markets where store re-openings and a return to normal living are driving social and professional occasions for resumed makeup use. The firm’s Q3 net sales increased 16%, reported, to approximately $3.86bn.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts